|
May 22, 2012, 03.26 PM IST
Pharmaceutical company Wockhardt has reported a consolidated net loss of Rs 192 crore for the fourth quarter of FY12 as against profit of Rs 162 crore in the corresponding quarter of last fiscal, due to exceptional loss of Rs 450 crore during the quarter.
By Ekta Batra, Research Analyst at CNBC-TV18
Pharmaceutical company Wockhardt has reported a consolidated net loss of Rs 192 crore for the fourth quarter of FY12 as against profit of Rs 162 crore in the corresponding quarter of last fiscal, due to exceptional loss of Rs 450 crore during the quarter. Consolidated net sales increased 32% year-on-year to Rs 1,241 crore in the quarter ended March 2012. EBITDA margins improved at 35% in the January-March quarter of 2012 as against 29% in a year ago period. Wockhardt earning a forex gain of Rs 55 crore during the quarter. Also watch the accompanying video...
Set email alert for Tags: Wockhardt, Ekta Batra
|
 From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'  The latest earning numbers FIRST on CNBC-TV18
News Videos
|
